Merrill A. McPeak, Director at IOVANCE BIOTHERAPEUTICS, INC. (IOVA), bought 20,000 shares at $6.31 ($126K) on 2022-11-29, disclosed to the SEC on 2022-11-30.
Open-market purchase of $126k IOVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.31 | 10,000 | $63K | 50.0% |
| 2 | $6.31 | 10,000 | $63K | 50.0% |
| Total | $6.31 avg | 20,000 | $126K | 100% |
| Filing → |
| IOVA | BUY | 2022-12-22 | $62K | — | Filing → |
| IOVA | BUY | 2022-11-28 | $62K | — | Filing → |
| IOVA | BUY | 2022-06-02 | $136K | — | Filing → |